|
SkyePharma's asthma drug wins European backing
Reuters UK LONDON (Reuters) – British pharmaceutical company SkyePharma said on Friday its asthma therapy Flutiform had been recommended for approval by European regulators, sending its shares soaring. Flutiform was referred to the European Medicines Agency (EMA) … |
View full post on asthma – Google News